VANCOUVER, BC, March 12, 2025 /PRNewswire/ - BTQ Technologies Corp. (the "Company") (CBOE CA: BTQ) (FSE: NG3) (OTCQX: BTQQF), a global quantum technology company focused on securing mission-critical networks, is pleased to announce the appointment of Dr. Gavin Brennen as Chief Quantum Officer (CQO). Dr. Brennen, who has already been serving as Quantum Information Advisor and Director of BTQ Australia, will now also drive the company's global technological roadmap and strategy.Dr. Brennen is a Professor of P ...

NEW YORK, March 12, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Quantum Computing Inc. ("Quantum Computing Inc." or the "Company") (NASDAQ: QUBT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Quantum Computing Inc. investors who were adversely affected by alleged securities fraud between March 30, 2020 and January 15, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslr ...

Core Insights - Quantum Computing Inc. (QCi) is participating in the 37th Annual ROTH Conference from March 16-18, 2025, in Dana Point, California, with CEO Dr. William McGann and CFO Chris Boehmler available for one-on-one meetings [1] Company Overview - Quantum Computing Inc. is an innovative company focused on integrated photonics and quantum optics technology, providing accessible and affordable quantum machines [3] - The company's products are designed to operate at room temperature and low power, making them cost-effective [3] - QCi's technology portfolio includes capabilities in high-performance computing, artificial intelligence, cybersecurity, and remote sensing applications [3]

Group 1 - Quantum-Si (NASDAQ: QSI) aims to introduce a scalable and cost-effective protein sequencing system, presenting a significant opportunity despite the challenges in protein sequencing [1] - Richard Durant leads Narweena, an asset manager focused on identifying market dislocations due to misunderstandings of long-term business prospects, targeting businesses with secular growth opportunities in markets with entry barriers [1] - Narweena's investment strategy emphasizes company and industry fundamentals to uncover unique insights, with a high risk appetite and a long-term investment horizon, particularly favoring deeply undervalued small-cap stocks [1] Group 2 - The aging population, low population growth, and stagnating productivity growth are expected to create a different set of investment opportunities compared to the past, with some industries facing stagnation or secular decline [1] - A trend towards asset-light businesses is emerging, leading to a declining need for infrastructure investments, which is resulting in a large pool of capital chasing limited investment opportunities, driving up asset prices and compressing risk premia [1] - Richard Durant holds undergraduate degrees in engineering and finance and an MBA, and has passed the CFA exams, indicating a strong educational background in finance and investment [1]

Melbourne, Victoria, Australia--(Newsfile Corp. - March 10, 2025) - Besra Gold Inc (ASX: BEZ) ("Besra" or the "Company") announces that Quantum requests a special meeting of the shareholders.In accordance with ASX Listing Rule 3.17A, the Board of Besra Gold Inc (Corporation) advises that it has received a requisition for a special meeting of the shareholders of the Corporation (Requisition) under Section 143 of the Canada Business Corporations Act (Act). The Requisition states, "Under Section 143 of the Ac ...

NEW YORK, March 10, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Quantum Computing Inc. (NASDAQ: QUBT).Shareholders who purchased shares of QUBT during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/quantum-computing-inc-loss-submission-form/?id=134614&from=4CLASS PERIOD: March 3 ...

Core Viewpoint - Investors are shifting their focus from established AI giants to emerging opportunities in quantum computing, with IonQ being highlighted as a potential leader in this space [1][2]. Group 1: Quantum Computing Landscape - Quantum computing is gaining attention as a new megatrend, with the potential to solve complex problems much faster than classical supercomputers [5]. - IonQ has seen a significant increase in its stock price, rising by 222% over the last six months, positioning itself as a key player in the quantum computing sector [3]. Group 2: Comparison with Nvidia - IonQ's CEO has drawn parallels between IonQ's current position and Nvidia's status prior to the AI revolution, suggesting that IonQ could experience similar growth [6]. - In 2015, Nvidia generated $4.7 billion in revenue with a market capitalization of approximately $11.3 billion, while IonQ is currently much smaller and facing a higher cash burn rate [7][8]. Group 3: Valuation Concerns - IonQ's stock trades at a price-to-sales (P/S) ratio exceeding 100, in stark contrast to Nvidia's P/S ratio of 2.4 in early 2015, indicating a significant premium on IonQ's valuation [9][10]. - Despite the potential of quantum computing, IonQ's rapid valuation increase raises concerns about its sustainability, especially given its low sales traction and high cash burn rate [11].

Corporate Updates - Quantum BioPharma Ltd. has announced the cancellation of 7,692 warrants previously granted to Michael (Zappy) Zapolin, as they no longer served as a realistic incentive [2][3] - The company has granted 7,692 stock options to Mr. Zapolin with an exercise price of C$6.60 per Class B Share, expiring on March 7, 2027 [4] - The option grant is classified as a related party transaction, requiring minority shareholder approval and a formal valuation, but the Board determined it was exempt from these requirements [5] Financial Activities - On March 6, 2025, the company closed a fourth tranche of a previously announced offering, issuing 100 Debenture Units for $100,000, which will be used for business development and working capital [6] - The company may close additional tranches with an increased conversion price of $6.60 and an increased exercise price per Warrant Share of $7.00 [6] Company Overview - Quantum BioPharma focuses on developing innovative assets and biotech solutions for neurodegenerative and metabolic disorders, with its lead compound, Lucid-MS, aimed at preventing and reversing myelin degradation [8][9] - The company retains a 25.71% ownership in Celly Nutrition Corp., which includes royalty payments of 7% of sales from its product unbuzzd™ until total payments reach $250 million, after which the royalty will drop to 3% [9]

NEW YORK, March 07, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Quantum Computing Inc. ("Quantum Computing Inc." or the "Company") (NASDAQ: QUBT) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Quantum Computing Inc. investors who were adversely affected by alleged securities fraud between March 30, 2020 and January 15, 2025. Follow the link below to get more information and be contacted by a member of our team: https://zlk.co ...

NEW YORK, March 7, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Quantum Computing Inc. ("Quantum Computing Inc." or the "Company") (NASDAQ: QUBT) of a class action securities lawsuit.CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Quantum Computing Inc. investors who were adversely affected by alleged securities fraud between March 30, 2020 and January 15, 2025. Follow the link below to get more information and be contacted by a member of our team:https://zlk.com/pslra ...